17
May
2011
Posted in I - Series A, Q - 1Q11, R - NORTH EAST, X - Computational Discovery, X - Metabolism, X - Oncology, XX - MA
Nimbus Discovery (Cambridge, MA) a development-stage biopharmaceutical focused on computational technologies to identify lead candidates for diffuse B-cell lymphoma and metabolic disease, closed a $1.5M Series A bringing the total financing to $5M. Participants include the Bill and Melinda Gates Foundation and Atlas Venture.
11
Feb
2010
08
Feb
2010